Interference in the vaccination of cattle against rinderpest virus by antibodies against peste des petits ruminants (PPR) virus.
The ability of the attenuated vaccine 75/1 of peste des petits ruminants to interfere with rinderpest vaccination in cattle was investigated experimentally. Young cattle (93) were selected and tested as being negative for antibodies against RP or PPR viruses. These were vaccinated with the peste des petits ruminants attenuated vaccine strain PPR75/1. All animals produced specific antibodies against the peste des petits ruminants vaccine after one or two doses. The cattle were then vaccinated with attenuated rinderpest vaccine. Two months later, 88 of these animals were sampled and 21/88 were positive for antibodies specific for rinderpest. The 67 negative animals received a second rinderpest vaccine dose after which 31seroconverted. The 36 animals which failed to seroconvert were re-vaccinated, of these 28 seroconverted. This study highlights the interference by peste des petits ruminants vaccination, presumably through production of antibodies that cross react with the live rinderpest virus in the vaccine used. This interference is also observed after vaccination against rinderpest followed by subsequent administration of peste des petits ruminants vaccine.
Couacy-Hymann
E
E
LANADA/Laboratoire Central de Pathologie Animale, BP 206 Bingerville, Côte-d'Ivoire. e.couacy-hymann@globeaccess.net
Bodjo
S C
SC
Danho
T
T
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002417:Cattle; D002418:Cattle Diseases / Q000517:prevention & control* / Q000821:virology; D003429:Cross Reactions; D029021:Peste-des-Petits-Ruminants / Q000276:immunology / Q000821:virology; D018107:Peste-des-petits-ruminants virus / Q000276:immunology*; D012301:Rinderpest / Q000517:prevention & control*; D012302:Rinderpest virus / Q000276:immunology*; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines